OLAYINKA TOBY: Open Payments
NPI 1740825413 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 9 payments from 3 companies in 2025. Trend: 2023 $681 · 2024 $305 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
